ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

N.J. Congressman Seeks Increase In Prevention Effort

March 10, 1978

“Start Fighting” Says Former Rep. John Porter To Crowd of 12,000 at AACR Washington Rally

April 12, 2013

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

NCAB Cool On CCOP, Ponders Questions On Distribution, Numbers Of Centers

December 11, 1981

Ohio State to study center expansion.

September 26, 2003

Bush Signs Bill To Increase Blood Cancer Research.

May 17, 2002